Search results

  1. Decision-making and mental capacity

    Everything NICE has said on decision-making for people who may, now or in the future, lack capacity to make their own decision in an interactive flowchart

  2. Evidence on the safety and efficacy of artificial iris implant insertion for acquired aniridia is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research.  Find out  what special arrangements mean on the NICE website .

    Recommendation ID IPG674 Question Evidence on the safety and efficacy of artificial iris implant insertion for acquired aniridia is limited

  3. Further research is recommended to assess the effect of test-guided preventive care (see section 5.1) on clinical outcomes (such as length of stay in hospital, mortality and need for renal replacement therapy and progression to chronic kidney disease). Research should be done in children, young people and adults, but specific considerations may be needed for children and young people when care differs from that for an adult population. Studies should investigate the effects of both positive and negative test results on clinical decisions and subsequent care.

    Recommendation ID DG39/2 Question Further research is recommended to assess the effect of test-guided preventive care (see section 5.1)

  4. Companies should specify patient populations in the NHS who could benefit from test-guided preventive care for acute kidney injury. Further research is then recommended in these populations to assess the clinical effectiveness of defined care bundles designed to prevent or reduce the effect of acute kidney injury in the NHS. Research should be done in children, young people and adults, but specific considerations may be needed for children and young people when care differs from that for an adult population (see  section 4.11 ).

    Recommendation ID DG39/1 Question Companies should specify patient populations in the NHS who could benefit from test-guided preventive

  5. Do the direct anterior, direct superior and supercapsular percutaneously assisted (SuperPATH) approaches to hip replacement improve patient-recorded outcome measures and reduce length of hospital stays, revision rates, neurological complications and surgical site infections compared with the posterior and anterolateral approaches?

    Recommendation ID NG157/11 Question Do the direct anterior, direct superior and supercapsular percutaneously assisted (SuperPATH) approaches

  6. 1.1 Evidence on the safety of electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease shows no major safety concerns. For people who are having an acute exacerbation of their chronic condition and are unable to exercise, evidence of efficacy is adequate to support the use of this procedure provided that standard arrangements are in place for clinical governance, consent and audit.   Find out  what standard arrangements mean on the NICE website . For people who are able to exercise, evidence on efficacy is inadequate in quality. Therefore, this procedure should only be used in the context of research. Find out  what only in research means on the NICE website .

    Recommendation ID IPG677 Question 1.1 Evidence on the safety of electrical stimulation to improve muscle strength in chronic respiratory

  7. Hepatitis B (chronic)

    Everything NICE has said on diagnosing and managing chronic hepatitis B in children, young people and adults in an interactive flowchart

  8. Evidence on the safety of transcranial magnetic stimulation for obsessive-compulsive disorder raises no major safety concerns. However, evidence on its efficacy is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research.  Find out  what only in research means on the NICE website .

    Recommendation ID IPG676 Question Evidence on the safety of transcranial magnetic stimulation for obsessive-compulsive disorder raises

  9. Motor neurone disease

    Everything NICE has said on assessing and managing motor neurone disease in adults in an interactive flowchart

  10. Eye conditions

    Everything NICE has said on eye conditions in an interactive flowchart

  11. Chronic heart failure

    Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart

  12. Myeloma

    Everything NICE has said on diagnosing and managing myeloma, and preventing and managing its complications in an interactive flowchart

  13. Cirrhosis

    Everything NICE has said on assessing and managing suspected or confirmed cirrhosis in people over 16 in an interactive flowchart

  14. Non-alcoholic fatty liver disease

    Everything NICE has said on diagnosing and managing non-alcoholic fatty liver disease and advanced liver fibrosis in an interactive flowchart

  15. Child abuse and neglect

    Everything NICE has said on child abuse and neglect in an interactive flowchart

  16. Autism spectrum disorder

    Everything NICE has said on recognition, referral, diagnosis and management of autism in an interactive flowchart

  17. Neonatal jaundice

    Everything NICE has said on diagnosing and treating jaundice in newborn babies under 28 days in an interactive flowchart

  18. Pancreatitis

    Everything NICE has said on pancreatitis in an interactive flowchart

  19. Organ donation for transplantation

    Everything NICE has said on improving donor identification and consent rates for deceased organ donation for transplantation in an interactive flowchart

  20. Neonatal parenteral nutrition

    Everything NICE has said on parenteral nutrition (intravenous feeding) for newborn babies in an interactive flowchart.

  21. Patient group directions

    Everything NICE has said on systems and processes to develop, authorise, use, and update patient group directions in an interactive flowchart

  22. Cardiovascular disease prevention

    Everything NICE has said on cardiovascular risk assessment and modifying blood lipids for preventing cardiovascular disease in adults

  23. Liver conditions

    Everything NICE has said on liver conditions in an interactive flowchart

  24. Liver cancers

    Everything NICE has said on liver and bile duct cancers in an interactive flowchart

  25. Alcohol-use disorders

    Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

  26. Local formulary development

    Everything NICE has said on systems and processes for developing and updating local formularies in an interactive flowchart

  27. Attention deficit hyperactivity disorder

    Everything NICE has said on diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults in an interactive flowchart

  28. Sepsis

    Everything NICE has said on the recognition, diagnosis and early management of sepsis in an interactive flowchart